Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NEWSOM-DAVIS, J.
Right arrow Articles by WILSON, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NEWSOM-DAVIS, J.
Right arrow Articles by WILSON, S. G.
NEUROLOGY 1978;28:266
© 1978 American Academy of Neurology

Function of circulating antibody to acetylcholine receptor in myasthenia gravis

Investigation by plasma exchange

J. NEWSOM-DAVIS, M.A., M.D., F.R.C.P., A. J. PINCHING, M.R.C.P., ANGELA VINCENT, M.B., M.Sc. and S. G. WILSON, B.Sc., M.R.C.P

Department of Neurological Science, Royal Free Hospital, London, England (Drs. Newsom-Davis, Vincent, and Wilson): the Department of Biophysics, University College, London, England (Dr. Vincent); and the Department of Medicine, Postgraduate Medical School, Hammersmith Hospital, London, England (Dr. Pinching).

Plasma exchange has been used to investigate the function of antiacetylcholine receptor (anti-AChR) antibody in seven patients with acquired myasthenia gravis (MG) who had elevated antibody titers and in one patient with congenital MG who had normal titers. There was an inverse association between clinical indices of muscle strength and anti-AChR titers, with a minimum time lag of 2 days for the clinical response. The inverse association of the clinical state with anti-AChR antibody titers was closer than that with total immunoglobulin G or other immunoglobulins, and is consistent with the view that the anti-AChR antibody is the principal factor interfering with neuromuscular transmission in acquired MG.

Dr. Newsom-Davis' address is Department of Neurological Science, Royal Free Hospital, Pond Street, London NW3 2QG, England.

Accepted for publication November 9, 1977.




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
W. F. Clark, G. A. Rock, N. Buskard, K. H. Shumak, P. LeBlond, D. Anderson, D. M. Sutton, and for the Canadian Apheresis Group*
Therapeutic Plasma Exchange: An Update from the Canadian Apheresis Group
Ann Intern Med, September 21, 1999; 131(6): 453 - 462.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
U. Besinger, K. Toyka, A. Anzil, A Fateh-Mognadam, R Rouscher, and K Heininger
Myeloma neuropathy: passive transfer from man to mouse
Science, August 28, 1981; 213(4511): 1027 - 1030.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by AAN Enterprises, Inc.